Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Méeus

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Bulletin Du Cancer|February 4, 2006
[News of the year 2005 in sarcomas]Jérôme Fayette, Pierre Méeus, Marie-Pierre Sunyach, et al.
BMC Cancer|March 19, 2013
Outcome of patients with advanced solitary fibrous tumors: the Centre Léon Bérard experienceAlice Levard, Olfa Derbel, Pierre Méeus, et al.
Bulletin Du Cancer|July 29, 2006
[Neoadjuvant chemotherapy and ovarian cancer]Isabelle Ray-Coquard, Chadi Saba, Thomas Bachelot, et al.
Cancer Management and Research|December 29, 2010
New developments in treatment of ovarian carcinoma: focus on trabectedinPhilippe A Cassier, Aude Duret, Olivier Trédan, et al.
Expert Opinion on Pharmacotherapy|September 15, 2011
Therapeutic pipeline for soft-tissue sarcomaPhilippe A Cassier, Sana Intidhar Labidi-Galy, Pierre Heudel, et al.
Current Opinion in Oncology|May 25, 2006
ET-743: a novel agent with activity in soft-tissue sarcomasJérôme Fayette, Isabelle Ray Coquard, Laurent Alberti, et al.
International Journal of Radiation Oncology, Biology, Physics|February 2, 2010
Phase I study of daily irinotecan as a radiation sensitizer for locally advanced pancreatic cancerChristelle de la Fouchardière, Sylvie Négrier, Hugues Labrosse, et al.
Bulletin Du Cancer|September 7, 2023
Gynecological carcinosarcomas: Overview and future perspectivesLaetitia Collet, Andrea María González López, Clémence Romeo, et al.
Bulletin Du Cancer|January 31, 2008
[Imatinib and solid tumours]Samia Arifi, Hiba El Sayadi, Armelle Dufresne, et al.
Expert Opinion on Pharmacotherapy|April 22, 2008
Imatinib mesilate for the treatment of gastrointestinal stromal tumourPhilippe A Cassier, Armelle Dufresne, Samia Arifi, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Bulletin Du Cancer|February 4, 2006
[News of the year 2005 in sarcomas]Jérôme Fayette, Pierre Méeus, Marie-Pierre Sunyach, et al.
BMC Cancer|March 19, 2013
Outcome of patients with advanced solitary fibrous tumors: the Centre Léon Bérard experienceAlice Levard, Olfa Derbel, Pierre Méeus, et al.
Bulletin Du Cancer|July 29, 2006
[Neoadjuvant chemotherapy and ovarian cancer]Isabelle Ray-Coquard, Chadi Saba, Thomas Bachelot, et al.
Cancer Management and Research|December 29, 2010
New developments in treatment of ovarian carcinoma: focus on trabectedinPhilippe A Cassier, Aude Duret, Olivier Trédan, et al.
Expert Opinion on Pharmacotherapy|September 15, 2011
Therapeutic pipeline for soft-tissue sarcomaPhilippe A Cassier, Sana Intidhar Labidi-Galy, Pierre Heudel, et al.
Current Opinion in Oncology|May 25, 2006
ET-743: a novel agent with activity in soft-tissue sarcomasJérôme Fayette, Isabelle Ray Coquard, Laurent Alberti, et al.
International Journal of Radiation Oncology, Biology, Physics|February 2, 2010
Phase I study of daily irinotecan as a radiation sensitizer for locally advanced pancreatic cancerChristelle de la Fouchardière, Sylvie Négrier, Hugues Labrosse, et al.
Bulletin Du Cancer|September 7, 2023
Gynecological carcinosarcomas: Overview and future perspectivesLaetitia Collet, Andrea María González López, Clémence Romeo, et al.
Bulletin Du Cancer|January 31, 2008
[Imatinib and solid tumours]Samia Arifi, Hiba El Sayadi, Armelle Dufresne, et al.
Expert Opinion on Pharmacotherapy|April 22, 2008
Imatinib mesilate for the treatment of gastrointestinal stromal tumourPhilippe A Cassier, Armelle Dufresne, Samia Arifi, et al.
Pageof 2